India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Brain waste disposal pathway found, signals new revolution in Alzheimer's treatment This discovery could completely change the understanding of how the brain stays healthy and why diseases like Alzheimer's develop. Scientists have discovered a new pathway for waste disposal in the human brain, which will help understand brain health and disease. Dr. Onder Albayram 's team at the Medical University of South Carolina used advanced MRI technology to detect fluid flow in the outer layer of the brain. This discovery has proven a direct connection between the brain and the body for waste disposal and could provide a new direction in the treatment of diseases like Alzheimer's. Kathmandu. Scientists have discovered a new pathway for waste disposal in the human brain. This discovery could completely change the understanding of how the brain stays healthy and why diseases like Alzheimer's develop. This study, conducted by researchers at the Medical University of South Ca...